Baker Brothers Advisors - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q2 2023$4,692,572
+562.8%
3,554,979
+1114.6%
0.03%
+800.0%
Q3 2021$708,000
-90.9%
292,692
-88.1%
0.00%
-91.2%
Q2 2021$7,796,000
-65.6%
2,459,399
-63.4%
0.03%
-65.3%
Q1 2021$22,646,000
+4.9%
6,719,948
+11.4%
0.10%
+21.0%
Q4 2020$21,588,0006,030,2930.08%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q3 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,972,958$4,775,0001.26%
Altium Capital Management LP 1,250,000$3,025,0000.79%
Rubric Capital Management LP 11,300,000$27,346,0000.76%
Vivo Capital, LLC 6,907,189$16,715,0000.75%
DAFNA Capital Management LLC 1,126,613$2,726,0000.72%
SILVERARC CAPITAL MANAGEMENT, LLC 365,661$885,0000.50%
Orbimed Advisors 17,264,764$41,781,0000.46%
Delphi Management Partners VIII, L.L.C. 256,734$621,0000.45%
Endurant Capital Management LP 746,514$1,807,0000.41%
Affinity Asset Advisors, LLC 650,000$1,573,0000.40%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders